Vanda Pharmaceuticals (VNDA) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,716.00 |
| Dec 31, 2025 | -4,374.00 |
| Sep 30, 2025 | -2,913.00 |
| Jun 30, 2025 | -2,541.00 |
| Mar 31, 2025 | -1,922.00 |
| Dec 31, 2024 | -1,282.00 |
| Sep 30, 2024 | -1,433.00 |
| Jun 30, 2024 | -1,357.00 |
| Mar 31, 2024 | -1,062.00 |
| Dec 31, 2023 | -1,058.00 |
| Sep 30, 2023 | -404.00 |
| Jun 30, 2023 | 201.00 |
| Mar 31, 2023 | 639.00 |
| Dec 31, 2022 | 1,368.00 |
| Sep 30, 2022 | 1,287.00 |
| Jun 30, 2022 | 1,136.00 |
| Mar 31, 2022 | 1,516.00 |
| Dec 31, 2021 | 1,990.00 |
| Sep 30, 2021 | 2,999.00 |
| Jun 30, 2021 | 3,578.00 |
| Mar 31, 2021 | 3,527.00 |
| Dec 31, 2020 | 3,022.00 |
| Sep 30, 2020 | -2,052.00 |
| Jun 30, 2020 | -2,474.00 |
| Mar 31, 2020 | -1,679.00 |
| Dec 31, 2019 | -1,161.00 |
| Sep 30, 2019 | 13,864.00 |
| Jun 30, 2019 | 10,181.00 |
| Mar 31, 2019 | 5,590.00 |
| Dec 31, 2018 | 2,630.00 |
| Sep 30, 2018 | 2,305.00 |
| Jun 30, 2018 | 2,195.00 |
| Mar 31, 2018 | 2,143.00 |
| Dec 31, 2017 | 1,307.00 |
| Sep 30, 2017 | 1,168.00 |
| Jun 30, 2017 | 1,093.00 |
| Mar 31, 2017 | 273.00 |
| Dec 31, 2016 | -488.00 |
| Sep 30, 2016 | -1,881.00 |